

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.35323324 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.29795891 |
| 3 | exogenous drug catabolic process (GO:0042738) | 9.22848013 |
| 4 | drug catabolic process (GO:0042737) | 8.93424737 |
| 5 | complement activation, alternative pathway (GO:0006957) | 8.55482793 |
| 6 | glyoxylate metabolic process (GO:0046487) | 8.44589889 |
| 7 | regulation of fibrinolysis (GO:0051917) | 8.39698118 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.10395932 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 8.10395932 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 7.72405595 |
| 11 | regulation of protein activation cascade (GO:2000257) | 7.67019999 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.38449445 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.38449445 |
| 14 | regulation of complement activation (GO:0030449) | 7.31092032 |
| 15 | * ethanol oxidation (GO:0006069) | 7.06744882 |
| 16 | urea metabolic process (GO:0019627) | 6.95957232 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.73450428 |
| 18 | protein carboxylation (GO:0018214) | 6.73450428 |
| 19 | fibrinolysis (GO:0042730) | 6.63839522 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 6.33764754 |
| 21 | oxidative demethylation (GO:0070989) | 6.20406278 |
| 22 | blood coagulation, intrinsic pathway (GO:0007597) | 6.11032785 |
| 23 | imidazole-containing compound metabolic process (GO:0052803) | 6.09742741 |
| 24 | urea cycle (GO:0000050) | 5.98409535 |
| 25 | * drug metabolic process (GO:0017144) | 5.98288599 |
| 26 | bile acid biosynthetic process (GO:0006699) | 5.90540497 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 5.90513201 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.89944770 |
| 29 | cellular glucuronidation (GO:0052695) | 5.81862778 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66910156 |
| 31 | * ethanol metabolic process (GO:0006067) | 5.63316363 |
| 32 | negative regulation of sterol transport (GO:0032372) | 5.55598390 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 5.55598390 |
| 34 | uronic acid metabolic process (GO:0006063) | 5.53099278 |
| 35 | glucuronate metabolic process (GO:0019585) | 5.53099278 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.44851557 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 5.40217957 |
| 38 | phenylpropanoid metabolic process (GO:0009698) | 5.38981373 |
| 39 | protein activation cascade (GO:0072376) | 5.32408710 |
| 40 | bile acid metabolic process (GO:0008206) | 5.21988831 |
| 41 | glycine metabolic process (GO:0006544) | 5.11036934 |
| 42 | complement activation (GO:0006956) | 5.08059072 |
| 43 | complement activation, classical pathway (GO:0006958) | 4.94858296 |
| 44 | negative regulation of blood coagulation (GO:0030195) | 4.87635891 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.87635891 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.81259318 |
| 47 | bile acid and bile salt transport (GO:0015721) | 4.78841264 |
| 48 | S-adenosylmethionine metabolic process (GO:0046500) | 4.74195115 |
| 49 | opsonization (GO:0008228) | 4.72313549 |
| 50 | regulation of humoral immune response (GO:0002920) | 4.62518043 |
| 51 | alkaloid metabolic process (GO:0009820) | 4.58165461 |
| 52 | glutamate metabolic process (GO:0006536) | 4.57186196 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.54190361 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.54190361 |
| 55 | acute-phase response (GO:0006953) | 4.50419865 |
| 56 | negative regulation of coagulation (GO:0050819) | 4.43235888 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 4.41939726 |
| 58 | negative regulation of wound healing (GO:0061045) | 4.39185803 |
| 59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.33198340 |
| 60 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.33198340 |
| 61 | cytolysis (GO:0019835) | 4.30236937 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27688524 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 4.27688524 |
| 64 | macromolecular complex remodeling (GO:0034367) | 4.27688524 |
| 65 | phospholipid efflux (GO:0033700) | 4.27279956 |
| 66 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.24506145 |
| 67 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.24506145 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 4.22493891 |
| 69 | positive regulation of hemostasis (GO:1900048) | 4.22493891 |
| 70 | alpha-amino acid catabolic process (GO:1901606) | 4.21415283 |
| 71 | high-density lipoprotein particle remodeling (GO:0034375) | 4.19734139 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 4.12369361 |
| 73 | cholesterol efflux (GO:0033344) | 4.11059329 |
| 74 | arginine metabolic process (GO:0006525) | 4.08445681 |
| 75 | amino-acid betaine metabolic process (GO:0006577) | 4.00881468 |
| 76 | indole-containing compound catabolic process (GO:0042436) | 3.95061884 |
| 77 | indolalkylamine catabolic process (GO:0046218) | 3.95061884 |
| 78 | tryptophan catabolic process (GO:0006569) | 3.95061884 |
| 79 | negative regulation of lipase activity (GO:0060192) | 3.92907767 |
| 80 | cellular ketone body metabolic process (GO:0046950) | 3.91139902 |
| 81 | positive regulation of coagulation (GO:0050820) | 3.87112924 |
| 82 | aromatic amino acid family metabolic process (GO:0009072) | 3.83505624 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 3.82435194 |
| 84 | reverse cholesterol transport (GO:0043691) | 3.77231250 |
| 85 | hormone catabolic process (GO:0042447) | 3.77065813 |
| 86 | negative regulation of complement activation (GO:0045916) | 3.76664775 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 3.61272512 |
| 88 | cellular amino acid catabolic process (GO:0009063) | 3.59985962 |
| 89 | flavonoid metabolic process (GO:0009812) | 3.56931256 |
| 90 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.56351508 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 3.52327768 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 3.49695385 |
| 93 | response to mercury ion (GO:0046689) | 3.48868540 |
| 94 | cysteine metabolic process (GO:0006534) | 3.47809342 |
| 95 | * xenobiotic metabolic process (GO:0006805) | 3.47318361 |
| 96 | acute inflammatory response (GO:0002526) | 3.43850685 |
| 97 | heme transport (GO:0015886) | 3.43109760 |
| 98 | ketone body metabolic process (GO:1902224) | 3.42995601 |
| 99 | sodium-independent organic anion transport (GO:0043252) | 3.41280838 |
| 100 | steroid catabolic process (GO:0006706) | 3.40284723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.12225283 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.12224112 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.94141929 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77096212 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.51468699 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70956473 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.42216146 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.34306831 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.80467294 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.39488082 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.13115716 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.05956023 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4497001 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.99309784 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.98834348 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95734229 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61335229 |
| 18 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42167616 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41534085 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40709356 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28594478 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26546920 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25572287 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24545938 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11367446 |
| 26 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04476220 |
| 27 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01213966 |
| 28 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01133482 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00829677 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91748626 |
| 31 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.91235656 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89067005 |
| 33 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88132441 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87044496 |
| 35 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85612918 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84569398 |
| 37 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82971187 |
| 38 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.81559419 |
| 39 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81086970 |
| 40 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76683019 |
| 41 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76189789 |
| 42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75781395 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75603422 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73896333 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.73047021 |
| 46 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72472977 |
| 47 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70825836 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.70398138 |
| 49 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.69651658 |
| 50 | NFYA_21822215_ChIP-Seq_K562_Human | 0.69248631 |
| 51 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.68635132 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68478733 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.68041304 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.67740777 |
| 55 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67559324 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.67489950 |
| 57 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67243099 |
| 58 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.64145567 |
| 59 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64068851 |
| 60 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63963367 |
| 61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61996546 |
| 62 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.61697937 |
| 63 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.61367525 |
| 64 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60840238 |
| 65 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.60597974 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.59516084 |
| 67 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.59413740 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.56433347 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.56022698 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.55994858 |
| 71 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.55648219 |
| 72 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.55507155 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55011118 |
| 74 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.54899827 |
| 75 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54760818 |
| 76 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.54568851 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54408442 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.54396486 |
| 79 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.53978545 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.53632206 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.53541355 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53202435 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52863234 |
| 84 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.52004158 |
| 85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.51837863 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.51756410 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.51306496 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.50391409 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.49762914 |
| 90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49760656 |
| 91 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.49455356 |
| 92 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49202835 |
| 93 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.49133558 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 0.49106215 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 0.48305302 |
| 96 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.48171753 |
| 97 | NFYB_21822215_ChIP-Seq_K562_Human | 0.48118732 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.47848791 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47748619 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.47479059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.58126356 |
| 2 | MP0005360_urolithiasis | 6.68464329 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.29553045 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 6.08703702 |
| 5 | MP0005365_abnormal_bile_salt | 5.58642570 |
| 6 | MP0003195_calcinosis | 5.00899640 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.06229623 |
| 8 | MP0003252_abnormal_bile_duct | 3.86070654 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.22150114 |
| 10 | MP0003868_abnormal_feces_composition | 3.21009637 |
| 11 | MP0009697_abnormal_copulation | 3.09503942 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.92492894 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.76865038 |
| 14 | MP0005332_abnormal_amino_acid | 2.38357624 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.33884468 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.91964441 |
| 17 | MP0009840_abnormal_foam_cell | 1.89798479 |
| 18 | MP0010368_abnormal_lymphatic_system | 1.89332038 |
| 19 | MP0000609_abnormal_liver_physiology | 1.87172568 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.69078002 |
| 21 | MP0001764_abnormal_homeostasis | 1.65953725 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.37295523 |
| 23 | MP0001661_extended_life_span | 1.28288373 |
| 24 | MP0009053_abnormal_anal_canal | 1.27397752 |
| 25 | MP0002132_abnormal_respiratory_system | 1.19974359 |
| 26 | MP0005670_abnormal_white_adipose | 1.15768131 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.15109559 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.11001413 |
| 29 | MP0005408_hypopigmentation | 1.10082416 |
| 30 | MP0000598_abnormal_liver_morphology | 1.06916783 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01410692 |
| 32 | MP0009764_decreased_sensitivity_to | 1.00444960 |
| 33 | MP0005451_abnormal_body_composition | 0.98662781 |
| 34 | MP0009643_abnormal_urine_homeostasis | 0.96195887 |
| 35 | MP0009763_increased_sensitivity_to | 0.91535949 |
| 36 | MP0002282_abnormal_trachea_morphology | 0.90218705 |
| 37 | MP0008872_abnormal_physiological_respon | 0.88493532 |
| 38 | MP0003186_abnormal_redox_activity | 0.85841760 |
| 39 | MP0000604_amyloidosis | 0.85783471 |
| 40 | MP0002971_abnormal_brown_adipose | 0.84394857 |
| 41 | MP0005376_homeostasis/metabolism_phenot | 0.83746563 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.82906202 |
| 43 | MP0008469_abnormal_protein_level | 0.79525939 |
| 44 | MP0001915_intracranial_hemorrhage | 0.76734004 |
| 45 | MP0005535_abnormal_body_temperature | 0.74933785 |
| 46 | MP0005187_abnormal_penis_morphology | 0.74111414 |
| 47 | MP0002249_abnormal_larynx_morphology | 0.73192230 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 0.71625074 |
| 49 | MP0005395_other_phenotype | 0.69746477 |
| 50 | MP0003879_abnormal_hair_cell | 0.67994849 |
| 51 | MP0003690_abnormal_glial_cell | 0.67693048 |
| 52 | MP0002168_other_aberrant_phenotype | 0.62515513 |
| 53 | MP0008874_decreased_physiological_sensi | 0.62247068 |
| 54 | MP0005266_abnormal_metabolism | 0.61225123 |
| 55 | MP0003011_delayed_dark_adaptation | 0.61131227 |
| 56 | MP0004130_abnormal_muscle_cell | 0.61068517 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 0.59868396 |
| 58 | MP0009785_altered_susceptibility_to | 0.58719122 |
| 59 | MP0005334_abnormal_fat_pad | 0.58648496 |
| 60 | MP0002078_abnormal_glucose_homeostasis | 0.58223821 |
| 61 | MP0005464_abnormal_platelet_physiology | 0.55053243 |
| 62 | MP0003638_abnormal_response/metabolism_ | 0.48768504 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.48420197 |
| 64 | MP0005166_decreased_susceptibility_to | 0.46877088 |
| 65 | MP0005023_abnormal_wound_healing | 0.46554033 |
| 66 | MP0003075_altered_response_to | 0.45309911 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.43559439 |
| 68 | MP0000249_abnormal_blood_vessel | 0.42418552 |
| 69 | MP0004883_abnormal_blood_vessel | 0.42365209 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.42268465 |
| 71 | MP0005164_abnormal_response_to | 0.38013384 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.37307054 |
| 73 | MP0000566_synostosis | 0.36282529 |
| 74 | MP0000467_abnormal_esophagus_morphology | 0.35921147 |
| 75 | MP0005448_abnormal_energy_balance | 0.35257192 |
| 76 | MP0005058_abnormal_lysosome_morphology | 0.35219371 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.29307543 |
| 78 | MP0005647_abnormal_sex_gland | 0.27850900 |
| 79 | MP0003953_abnormal_hormone_level | 0.26490728 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.25746825 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 0.25746825 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.25387292 |
| 83 | MP0009115_abnormal_fat_cell | 0.24847927 |
| 84 | MP0003718_maternal_effect | 0.23498997 |
| 85 | MP0001851_eye_inflammation | 0.23189365 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.23031787 |
| 87 | MP0000639_abnormal_adrenal_gland | 0.21658482 |
| 88 | MP0008873_increased_physiological_sensi | 0.19997971 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.19373413 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.17717346 |
| 91 | MP0002970_abnormal_white_adipose | 0.17625001 |
| 92 | MP0005083_abnormal_biliary_tract | 0.17621588 |
| 93 | MP0005197_abnormal_uvea_morphology | 0.17077283 |
| 94 | MP0003436_decreased_susceptibility_to | 0.16755304 |
| 95 | MP0002090_abnormal_vision | 0.16713822 |
| 96 | MP0001756_abnormal_urination | 0.16503238 |
| 97 | MP0002128_abnormal_blood_circulation | 0.16429502 |
| 98 | MP0001440_abnormal_grooming_behavior | 0.16194943 |
| 99 | MP0001881_abnormal_mammary_gland | 0.15515601 |
| 100 | MP0003959_abnormal_lean_body | 0.15178004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 9.95145651 |
| 2 | Deep venous thrombosis (HP:0002625) | 9.90951411 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 9.33429655 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.78845385 |
| 5 | Abnormality of complement system (HP:0005339) | 8.05769002 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.49269670 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 6.67674551 |
| 8 | Joint hemorrhage (HP:0005261) | 6.57240636 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 6.54083019 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.96585794 |
| 11 | Glomerulonephritis (HP:0000099) | 5.28807321 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 5.09169948 |
| 13 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.92010629 |
| 14 | Xanthomatosis (HP:0000991) | 4.90324383 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.85500676 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.43671336 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.37308062 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.23820495 |
| 19 | Spontaneous abortion (HP:0005268) | 4.03492285 |
| 20 | Nephritis (HP:0000123) | 3.95220243 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.92521875 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77988815 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.52571261 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.48299646 |
| 25 | Hyperglycinemia (HP:0002154) | 3.42330134 |
| 26 | Neonatal hypoglycemia (HP:0001998) | 3.20298739 |
| 27 | Hyperammonemia (HP:0001987) | 3.19443630 |
| 28 | Delayed CNS myelination (HP:0002188) | 3.18111042 |
| 29 | Fat malabsorption (HP:0002630) | 3.13352333 |
| 30 | Fair hair (HP:0002286) | 3.09123496 |
| 31 | Generalized aminoaciduria (HP:0002909) | 2.93720132 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.92494432 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 2.92494432 |
| 34 | Gingival bleeding (HP:0000225) | 2.83787168 |
| 35 | Hypercholesterolemia (HP:0003124) | 2.82219040 |
| 36 | Mitral stenosis (HP:0001718) | 2.81844663 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.75084892 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.73379119 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.72594621 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 2.70960226 |
| 41 | Epidermoid cyst (HP:0200040) | 2.70929103 |
| 42 | Osteomalacia (HP:0002749) | 2.68082296 |
| 43 | Hyperbilirubinemia (HP:0002904) | 2.62844980 |
| 44 | Vascular calcification (HP:0004934) | 2.62525286 |
| 45 | Thrombophlebitis (HP:0004418) | 2.59886284 |
| 46 | Rickets (HP:0002748) | 2.56119773 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.52863699 |
| 48 | Purpura (HP:0000979) | 2.52436074 |
| 49 | Steatorrhea (HP:0002570) | 2.47113146 |
| 50 | Menorrhagia (HP:0000132) | 2.46620461 |
| 51 | Pulmonary embolism (HP:0002204) | 2.44388178 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.38773936 |
| 53 | Hyperglycinuria (HP:0003108) | 2.36490228 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.33525832 |
| 55 | Generalized hypopigmentation of hair (HP:0011358) | 2.17657609 |
| 56 | Reduced antithrombin III activity (HP:0001976) | 2.17106559 |
| 57 | Metabolic acidosis (HP:0001942) | 2.16766629 |
| 58 | Cholelithiasis (HP:0001081) | 2.10357305 |
| 59 | Abnormal gallbladder physiology (HP:0012438) | 2.08937007 |
| 60 | Cholecystitis (HP:0001082) | 2.08937007 |
| 61 | Ketosis (HP:0001946) | 2.08782332 |
| 62 | Hyperphosphaturia (HP:0003109) | 2.04804567 |
| 63 | Myocardial infarction (HP:0001658) | 2.03253962 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.01436927 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.6304775 |
| 66 | Arthropathy (HP:0003040) | 1.98256179 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 1.96986921 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 1.96702643 |
| 69 | Blue irides (HP:0000635) | 1.93269951 |
| 70 | Elevated alkaline phosphatase (HP:0003155) | 1.90207788 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 1.90005672 |
| 72 | Irritability (HP:0000737) | 1.89366307 |
| 73 | Increased serum ferritin (HP:0003281) | 1.88080333 |
| 74 | Abnormality of vitamin metabolism (HP:0100508) | 1.84183063 |
| 75 | Gangrene (HP:0100758) | 1.82864603 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 1.80761564 |
| 77 | Glycosuria (HP:0003076) | 1.80761564 |
| 78 | Bifid scrotum (HP:0000048) | 1.79981780 |
| 79 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78103187 |
| 80 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75631437 |
| 81 | Increased mean platelet volume (HP:0011877) | 1.74568875 |
| 82 | Hypophosphatemic rickets (HP:0004912) | 1.73423929 |
| 83 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72553444 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 1.72028951 |
| 85 | Alkalosis (HP:0001948) | 1.71348395 |
| 86 | Epistaxis (HP:0000421) | 1.71343009 |
| 87 | Joint swelling (HP:0001386) | 1.70887197 |
| 88 | Atrioventricular block (HP:0001678) | 1.64630795 |
| 89 | Cerebral palsy (HP:0100021) | 1.63134642 |
| 90 | Abnormal urine phosphate concentration (HP:0012599) | 1.62685019 |
| 91 | Skin nodule (HP:0200036) | 1.61536530 |
| 92 | Poikilocytosis (HP:0004447) | 1.61123352 |
| 93 | Abnormal platelet volume (HP:0011876) | 1.57881541 |
| 94 | Lethargy (HP:0001254) | 1.57023495 |
| 95 | Reticulocytosis (HP:0001923) | 1.53522660 |
| 96 | Pancreatitis (HP:0001733) | 1.50516493 |
| 97 | Impaired platelet aggregation (HP:0003540) | 1.48945517 |
| 98 | Abnormal platelet function (HP:0011869) | 1.48945517 |
| 99 | Neonatal onset (HP:0003623) | 1.48679848 |
| 100 | Cerebral edema (HP:0002181) | 1.47061259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.16584044 |
| 2 | FGFR4 | 4.36522455 |
| 3 | TRIB3 | 3.49541078 |
| 4 | SIK1 | 3.34372645 |
| 5 | BCKDK | 3.08090946 |
| 6 | TYK2 | 2.81963141 |
| 7 | RIPK1 | 2.80695221 |
| 8 | PIK3CA | 2.51043786 |
| 9 | PIK3CG | 2.48472692 |
| 10 | PRKACG | 2.41552923 |
| 11 | PRPF4B | 2.20566377 |
| 12 | PRKAA2 | 1.95053533 |
| 13 | MAP2K4 | 1.87696774 |
| 14 | MAPK11 | 1.82029821 |
| 15 | NTRK3 | 1.81719724 |
| 16 | PRKCG | 1.64221324 |
| 17 | EPHA3 | 1.57551385 |
| 18 | FGFR3 | 1.51888378 |
| 19 | PINK1 | 1.44750643 |
| 20 | LATS1 | 1.44400162 |
| 21 | IGF1R | 1.41540992 |
| 22 | TAOK3 | 1.40983430 |
| 23 | ABL2 | 1.40039154 |
| 24 | MST1R | 1.37085276 |
| 25 | JAK1 | 1.26722945 |
| 26 | TNK2 | 1.21652351 |
| 27 | MAP3K3 | 1.20357974 |
| 28 | TBK1 | 1.19278396 |
| 29 | NEK9 | 1.16712503 |
| 30 | CSF1R | 1.15667622 |
| 31 | PRKG1 | 1.15475455 |
| 32 | ERBB2 | 1.15048038 |
| 33 | PKN2 | 1.14638985 |
| 34 | TIE1 | 1.13386973 |
| 35 | PDPK1 | 1.13251769 |
| 36 | NLK | 1.11755384 |
| 37 | PRKCZ | 1.06217438 |
| 38 | MYLK | 1.05937070 |
| 39 | JAK2 | 1.05127049 |
| 40 | EPHA4 | 1.04582858 |
| 41 | PRKACA | 0.97670116 |
| 42 | MAPK7 | 0.96191978 |
| 43 | PDK2 | 0.94014001 |
| 44 | CDK6 | 0.92225426 |
| 45 | CAMKK2 | 0.91418942 |
| 46 | KDR | 0.86917336 |
| 47 | MAPK12 | 0.86723590 |
| 48 | PRKAA1 | 0.82641481 |
| 49 | TGFBR2 | 0.81413224 |
| 50 | FER | 0.74443722 |
| 51 | DYRK1B | 0.73794880 |
| 52 | AKT3 | 0.70785940 |
| 53 | RET | 0.70740364 |
| 54 | PDK1 | 0.70012211 |
| 55 | MAP3K1 | 0.69889046 |
| 56 | BRSK2 | 0.67718097 |
| 57 | MAP3K2 | 0.67616429 |
| 58 | KIT | 0.66885506 |
| 59 | CSNK1D | 0.65863813 |
| 60 | FGFR2 | 0.65106631 |
| 61 | RPS6KA3 | 0.64662881 |
| 62 | MAPK4 | 0.63330505 |
| 63 | PRKCA | 0.63240700 |
| 64 | BLK | 0.62751012 |
| 65 | CAMKK1 | 0.62301767 |
| 66 | ZAP70 | 0.62175312 |
| 67 | PRKCB | 0.62057115 |
| 68 | INSRR | 0.61074502 |
| 69 | SGK494 | 0.60987182 |
| 70 | SGK223 | 0.60987182 |
| 71 | TAOK2 | 0.59339789 |
| 72 | ICK | 0.56959862 |
| 73 | SGK1 | 0.56430623 |
| 74 | MAP3K11 | 0.56176610 |
| 75 | DAPK2 | 0.54734655 |
| 76 | SRC | 0.52365751 |
| 77 | MET | 0.51806641 |
| 78 | GSK3A | 0.51407794 |
| 79 | MAP3K6 | 0.51175801 |
| 80 | PTK6 | 0.49254918 |
| 81 | PRKACB | 0.49173634 |
| 82 | EPHB1 | 0.48323409 |
| 83 | SGK2 | 0.47006090 |
| 84 | CDK4 | 0.46979547 |
| 85 | STK38 | 0.45198470 |
| 86 | CAMK1D | 0.45055802 |
| 87 | IKBKE | 0.44034758 |
| 88 | CAMK2G | 0.43361680 |
| 89 | SGK3 | 0.42129882 |
| 90 | CSNK2A1 | 0.41405173 |
| 91 | CSNK1E | 0.40769584 |
| 92 | CSNK2A2 | 0.36741154 |
| 93 | ARAF | 0.36428251 |
| 94 | STK16 | 0.34802954 |
| 95 | WNK3 | 0.34634604 |
| 96 | MAPK3 | 0.34323525 |
| 97 | CAMK4 | 0.33151999 |
| 98 | MTOR | 0.31479507 |
| 99 | MAP2K2 | 0.31364242 |
| 100 | CSNK1A1 | 0.30782237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.53417778 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.22739442 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.96480000 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94531538 |
| 5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.43791448 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37721409 |
| 7 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.33760201 |
| 8 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.89590014 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.89506747 |
| 10 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.85822254 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75550960 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.60686336 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.58229137 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.55210251 |
| 15 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.48545293 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.46887686 |
| 17 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 2.33674471 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.23898181 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18205301 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85673288 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81941985 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.80096505 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.72432670 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.68018120 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56530895 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50251336 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45110700 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43829722 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36204702 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35604150 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32290825 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.30084721 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29512794 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26392201 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.23336180 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20772236 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17912955 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12356113 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02916853 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99960865 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98454074 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98430963 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94984170 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94558019 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94465655 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86892265 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85833109 |
| 48 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82443468 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77530567 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70092533 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.69855497 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66399466 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61286366 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58647290 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57773590 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.47479537 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46657254 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42647517 |
| 59 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41356600 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.33997850 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28143015 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.23914385 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23749751 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23716375 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19258368 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18408963 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17292859 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.13445169 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07782705 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06050842 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05623348 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.04992296 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.01850467 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01686446 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01299839 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.00089581 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.3010062 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2590714 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2584739 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2552804 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2520937 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2420092 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2205211 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2084803 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1976082 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1847879 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1368742 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1352540 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1331432 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.1081537 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1016421 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0932538 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0794507 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0663262 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0656730 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0588857 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | -0.0559331 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0375290 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0345823 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.0008723 |

